Clinical Trial: A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Overweight
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label, Single and Multiple Dose Study to Investigate the Safety, Tolerability, and Relative Bioavailability of Single and Multiple Weekly Subcutaneous Doses of Eloralintide, and Single
Brief Summary:
The purpose of this study is to evaluate how well eloralintide and eloralintide with tirzepatide is tolerated and what side effects may occur in participants with overweight or obesity.The study drug will be administered subcutaneously (SC) (under the skin).Blood tests will be performed to check how much eloralintide and eloralintide with tirzepatide get into the bloodstream and how long it takes the body to eliminate it.There will be 6 cohorts.The study will last up to approximately 26 weeks, excluding screening…
Read more